Letter – COVID: In A Time of Macro Crisis: We Would Like to Thank our Clients

Dear Friends and Colleagues
It has been an extraordinary past month in global financial markets, and for Exante Data as well. We are writing today with an update, and with concern, as we are expecting a very significant escalation in reported COVID cases in the US in the period ahead, as testing commences on a broader scale.
First, on behalf of the entire Exante team, I would like to thank our clients. We have received an enormous amount of feedback across our global client base. We have incorporated your thinking and your insights in setting our analytical priorities. We have also been inspired and humbled by all the kind words. We have taken the additional step of asking some of you for formal testimonials. Thank you for these as well. We have posted these on our website today, on a strictly anonymized basis.
Second, some words on our journey. We recognized COVID as a market driver as early as Jan 21, and conveyed those impressions in real-time. As our concerns intensified, we instituted our Daily coronavirus coverage on Jan 28. We augmented our Daily with open-source statistics of China’s return to work from Feb 10 (now on @exantedata as a free service). Our response has been agile and comprehensive, geared toward staying ahead of the analytical curve, so as to provide a ‘full stack’ of deliverables to each of you. 
Everyone at Exante has been focused on this priority. It has been a huge team effort. Grant Wilson in Sydney deserves a special credit for insisting VERY early on the topic’s immense global significance and for spearheading our Daily initiative. I am very proud of the entire team’s efforts, including also the contributions of Alex Etra, Web Begole, Fabio Palacio, and Patrick Mcbrearty in New York.
I believe that this period has been a strong validation of Exante’s independent ethos and data-driven approach. We recognized early the importance of deferring key analytics to the epidemiological community, whose work we knew from the SARS episode. We have been careful to ‘stay in our lane’ in that respect. We have now come full circle, with top research epidemiologists coming to us, to lever our real-time data in their analysis!
Even as COVID has broadened, we have found ways to stay ahead of developments, using our data and software development skills. This has informed our macro thematic notes, and our underlying platform, Global Flow Analytics, as well. In a large institutional setting the steps we took, and will continue to take, are simply not feasible
Through February we are pleased to convey that Exante has experienced non-linear growth, adding subscribers across the world, and across many sectors as well. To those of you who are new, thank you for the engagement and the opportunity.
A final note. As extraordinary as this period has been at Exante, we are all deeply mindful that beneath the data there are real people. We expect the human aspect to be felt more keenly globally over the next couple of weeks and we have elevated concerns about the US in this context. 
Please accept our best wishes at this time, and our sincere thanks as we help to navigate what lies ahead. And please keep the questions coming; we are here to help.


Thanks again

Jens Nordvig

Founder and CEO

Exante Data Inc.



Exante Data © 2021. All rights reserved. Personal Data Usage Policy

This site is provided for informational purposes only.  The information included in this site should not be used as the sole basis for making a decision as to whether or not to invest in any particular security. In making an investment decision, you must rely on your own examination of the securities and the terms of the offering. You should not construe the contents of these materials as legal, tax, investment or other advice, or a recommendation to purchase or sell any particular security.

The information included in this site is based upon information reasonably available to Exante as of the date noted herein. Furthermore, the information included in this site has been obtained from sources that Exante believes to be reliable; however, these sources cannot be guaranteed as to their accuracy or completeness. Information contained in this site does not purport to be complete, nor does Exante undertake any duty to update the information set forth herein. No representation, warranty or undertaking, express or implied, is given as to the accuracy or completeness of the information contained herein, by Exante, its members, partners or employees, and no liability is accepted by such persons for the accuracy or completeness of any such information.

This site contains certain “forward-looking statements,” which may be identified by the use of such words as “believe,” “expect,” “anticipate,” “should,” “planned,” “estimated,” “potential,” “outlook,” “forecast,” “plan” and other similar terms. Examples of forward-looking statements include, but are not limited to, estimates with respect to financial condition, results of operations, and success or lack of success of certain investment strategy. All are subject to various factors, including, but not limited to, general and local economic conditions, changing levels of competition within certain industries and markets, changes in interest rates, changes in legislation or regulation, and other economic, competitive, governmental, regulatory and technological factors affecting the operations of the companies identified herein, any or all of which could cause actual results to differ materially from projected results.

Get more information about Exante Data
Get Ahead With Our Updates with Our Exante Newsletter